Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/NICORAMA MINT 2 MG CHICLES MEDICAMENTOSOS EFG

Approved

STANDARD

NICORAMA MINT 2 MG CHICLES MEDICAMENTOSOS EFG

Enorama Pharma Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 16, 2021
Approval ID: 71c7d96c54e32624
Company: Enorama Pharma Ab
Type: Standard

Approval Details

Approval Id: 71c7d96c54e32624
Drug Cima Aemps Name: NICORAMA MINT 2 MG CHICLES MEDICAMENTOSOS EFG
Register Number: 85467
Holder Company Name: Enorama Pharma Ab
Marketing Company Name: Enorama Pharma Ab
Authorization Date: 2021-03-16
Dosage Form: CHICLE MEDICAMENTOSO
Dose: 2 mg
Route Of Administration: Vía bucal (buccal use)
Prescription Type: Sin Receta
Commercialized: No
Company Name: Enorama Pharma Ab

Active Ingredients

NICOTINA RESINATO

10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 16, 2021

Approval ID

71c7d96c54e32624

Type

Standard

Back to CIMA-AEMPS Approvals

NICORAMA MINT 2 MG CHICLES MEDICAMENTOSOS EFG - CIMA-AEMPS Drug Approval Details